Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC Kardigan™, a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases…
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting Incyte announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor,…
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care Takeda announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2…
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session Corcept Therapeutics Incorporated a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the…
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device (SaMD)…
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo Arrowhead Pharmaceuticals, Inc. announced long-term efficacy and safety data from a two-year long…
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update Alpha Cognition Inc. a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025,…
Aledade Partners Achieve Superior Hypertension Control Outperforming Large Health Systems in New Case Study Aledade, a physician-led, national leader in value-based care, announced the results of a new case study demonstrating how its network of primary care clinicians is successfully controlling hypertension…
Nordic Cold Chain Solutions Launches GLP-1 & Small-Format Packaging Innovation Lab Nordic Cold Chain Solutions today announced the launch of its GLP-1 & Small-Format Packaging Innovation Lab, a customer-first initiative designed to help specialty pharmacies, pharmaceutical manufacturers, and e-commerce leaders…
Drug Farm Announces U.S. FDA Orphan Drug Designation for DF-003 for the Treatment of ROSAH Syndrome Drug Farm today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to DF-003, the company’s investigational small…
Healthcare Digital Wins 2026 Artificial Intelligence Excellence Award for Nutrition AI, Developed in Collaboration with Morrison Healthcare Healthcare Digital, the healthcare and senior living division of Compass Digital and the technology arm for Compass Healthcare, today announced it has been named a winner…
Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations Xaira Therapeutics announced the appointment of Dr. Rachel Lane as Senior Vice President, Business Development and Operations, reporting to President and COO Jeff…